RBKTX | REGTX | RBKTX / REGTX | |
Total Expense Ratio | 1.45 | 0.41 | 354% |
Annual Report Gross Expense Ratio | 1.45 | 0.41 | 354% |
Fund Existence | 19 years | 19 years | - |
Gain YTD | 14.819 | 15.690 | 94% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 50B | 50B | 100% |
Annual Yield % from dividends | 0.52 | 1.35 | 38% |
Returns for 1 year | 13.30 | 14.60 | 91% |
Returns for 3 years | 42.97 | 46.67 | 92% |
Returns for 5 years | 38.33 | 44.15 | 87% |
Returns for 10 years | 86.71 | 96.39 | 90% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GLOW | 29.87 | 0.43 | +1.46% |
VictoryShares WestEnd Global Equity ETF | |||
QTEC | 219.92 | 2.00 | +0.92% |
First Trust NASDAQ-100-Tech Sector ETF | |||
LEO | 6.20 | 0.02 | +0.32% |
BNY Mellon Strategic Municipals | |||
BBC | 24.00 | -0.12 | -0.50% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
BMVP | 48.79 | -0.32 | -0.65% |
Invesco Bloomberg MVP Multi-factor ETF |